NASDAQ$BIOLQ

Biolase Inc · Q3 2023 earnings

Q3 2023 earnings · · Investor relations

Briefing

Announced third quarter financial results, benefiting from strategic actions to streamline operations and gain greater operational efficiencies.

BIOLASE reported Q3 2023 financial results with a total revenue of $10.9 million. The company experienced a decrease in overall revenue compared to the previous year, but saw a 10% year-over-year increase in total consumable sales. Gross margin improved significantly to 34%, and the operating loss was reduced by 52% year over year.

  • Total revenue was $10.9 million, impacted by the current macro-environment.
  • Total consumable sales increased by 10% year-over-year.
  • Gross margin was 34%, a 1,400-basis expansion compared to the year-ago level.
  • Operating loss decreased by 52% year over year.

Headline financials

Total Revenue

$10.9M

Previous: $12M-9.1%
EPS (adj)

-$10.35

Previous: -$110.36+90.6%
Capital Expenditures

-$182K

Previous: $2.68M-106.8%
Free Cash Flow

-$2.77M

Previous: -$9.22M+70.0%
Net Income

-$4.59M

Previous: -$8.4M+45.4%
Operating Income

-$3.7M

Previous: -$7.7M+52.0%
Gross Profit

$3.75M

Previous: $2.45M+53.2%
Cash & Equivalents

$7.81M

Previous: $9.96M-21.6%
Total Assets

$38.7M

Previous: $42.9M-9.6%
R&D Expense

$1.36M

No prior period
Stock-Based Comp

$275K

Previous: $591K-53.5%

Revenue & EPS history

Biolase · Revenue · Quarterly

$10.9M

Q3 2023-9.1%vs Q3 2022
Beat estimate in 7 of 13 quarters(54%)
ActualEstimate

Revenue by segment

Biolase · $6.7M total across 2 segments · Q3 2023

  • US Laser Revenue
    $3.8M-17.4%
  • International Laser Revenue
    $2.9M

Forward guidance

The Company currently expects full year 2023 revenue to be 1 to 3% higher than full year 2022 revenue. In addition, the Company expects net loss from operations for both the full year 2023 and for the fourth quarter of 2023 to be significantly improved compared to the comparable periods for the prior year.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2023

Historical avgQ3 2023

-3.0%

Avg return

Earnings day

-6.6%

Avg return

5 days after

-13.5%

Avg return

30 days after

41%

24 / 58 earnings

Positive

+25.4%

Q2 2021

Best reaction

-45.7%

Q1 2020

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q3 2024-18.9%-9.9%+26.1%
Q2 2024+7.8%-10.0%-30.0%
Q1 2024+1.8%-10.8%-21.9%
Q4 2024+20.3%+7.5%-6.8%
Q3 2023-22.0%-17.3%-23.4%
Q2 2023-19.5%-6.2%-50.2%
Q1 2023-6.7%-15.4%-17.4%
Q4 2022-10.8%-24.8%-43.8%
Q3 2022+16.3%+27.7%-49.2%
Q2 2022-1.1%-5.3%-33.6%
Q1 2022+0.0%-2.0%-47.1%
Q4 2021+2.9%+4.1%-9.3%
Q3 2021-8.2%-17.9%-34.5%
Q2 2021+25.4%+5.7%+10.0%
Q1 2021-1.2%-1.5%-10.8%
Q3 2020-3.3%-10.4%-0.8%
Q2 2020-2.4%-4.7%-28.9%
Q1 2020-45.7%-49.0%-6.0%
Q4 2019-22.4%-52.1%-7.3%
Q3 2019-5.8%+6.3%+2.9%
Q2 2019-7.7%-12.3%-36.1%
Q1 2019+2.5%-8.4%-13.9%
Q4 2018-16.5%-18.0%-21.6%
Q3 2018-9.3%-9.3%-27.9%
Q2 2018+9.5%+29.9%+60.6%
Q1 2018-2.4%+1.1%-13.1%
Q4 2017-4.1%-7.8%-36.7%
Q3 2017+0.0%+0.0%-25.0%
Q2 2017-29.8%-32.3%-28.8%
Q1 2017-3.8%-3.0%-3.8%
Q4 2016-2.5%-4.2%+5.8%
Q3 2016+20.8%+20.1%+18.8%
Q2 2016+1.8%+12.4%+56.6%
Q1 2016-12.3%
Q4 2015-0.8%
Q3 2015+8.5%
Q2 2015+6.3%
Q1 2015+1.0%
Q4 2014-2.5%
Q3 2014-3.3%
Q2 2014+1.4%
Q1 2014-0.8%
Q4 2013+0.7%
Q3 2013-11.8%
Q2 2013-22.7%
Q1 2013+3.5%
Q4 2012+1.0%
Q3 2012+10.6%
Q2 2012-1.2%
Q1 2011+0.8%
Q1 2012+1.8%
Q4 2011+0.5%
Q4 2009+0.5%
Q3 2011+4.9%
Q3 2010+4.9%
Q2 2010-10.2%
Q4 2010-10.2%
Q2 2011-10.2%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro